Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Listent Medical is a China-based medtech company focused on cochlear implants and related hearing restoration technologies. Founded in 2004 in Shanghai, the company was built on cochlear implant research originating from the Eye and ENT Hospital of Fudan University and has developed indigenous implantable hearing devices for patients with severe to profound hearing loss. Its core commercial product family includes the LISTENT LCI-20PI cochlear implant system and associated external speech processors, and published clinical studies report safety and effectiveness in both post-lingually deafened individuals and prelingually deafened children. The company appears to operate as an active private medical device manufacturer with Class II/III device production capabilities in China. Listent is positioned as a domestic Chinese cochlear implant developer and manufacturer rather than a therapeutic biotech or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Listent Medical.